In this review, we have discussed specifically what is known on the cross-talk between Hh and Wnt signaling pathways in BCC development, based on the literature covering the last two decades and the potential relevance of this cross-talk in the treatment of SMO inhibitors’ resistant BCCs. The gene discussed is SMO; the disease is skin basal cell carcinoma.